South Carolina Sci-Tech Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on South Carolina Sci-Tech Wire.

Press releases published on October 22, 2026

2 hours ago

SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases

Indeterminate GlobeNewswire

2 hours ago

Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases

Indeterminate GlobeNewswire

2 hours ago

Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026

Indeterminate GlobeNewswire

2 hours ago

Teads to Release Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

2 hours ago

Climb Global Solutions Acquires NeoVAD, Building Greater Scale in France

Indeterminate GlobeNewswire

2 hours ago

The National Cybersecurity Alliance and CybSafe’s Oh, Behave! Report Finds Cybersecurity Awareness Is High – and People Are Ready to Act

Indeterminate GlobeNewswire

2 hours ago

Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility

Indeterminate GlobeNewswire

2 hours ago

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

Indeterminate GlobeNewswire

2 hours ago

Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement

Indeterminate GlobeNewswire

2 hours ago

Annovis to Attend the CTAD 2026 with Three Presentations

Indeterminate GlobeNewswire

2 hours ago

Aduro Clean Technologies to Engage Industry and Institutional Investors at Five Conferences Through Year-End 2026

Indeterminate GlobeNewswire

2 hours ago

Rgenta Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Trial Design for RGT-61159 in Patients with Adenoid Cystic Carcinoma (ACC)

Indeterminate GlobeNewswire

2 hours ago

3 E Network Commences Phased Delivery of Approximately $5.0 Million Core Storage Hardware Order

Indeterminate GlobeNewswire

2 hours ago

ZenaTech Unveils its Proprietary AI Software Suite Designed to Accelerate Land Survey Delivery for Drone as a Service Commercial, Municipal and Infrastructure Clients

Indeterminate GlobeNewswire

2 hours ago

SalesCloser Files New U.S. Patent Application Covering Dynamic Multi-Agent Participation and Orchestration in Live Calls

Indeterminate GlobeNewswire

2 hours ago

Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development

Indeterminate GlobeNewswire

2 hours ago

BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire

2 hours ago

Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor

Indeterminate GlobeNewswire

2 hours ago

Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Indeterminate GlobeNewswire

2 hours ago

Google and Voltus Announce One Gigawatt Bring Your Own Capacity Agreement in PJM

Indeterminate GlobeNewswire